Everolimus
Trade Name:
Afinitor
Manufacturer/Distributor:
Novartis
1-800-363-8883 or medinfo.canada@novartis.com
Classification:
Antineoplastic agent
ATC Class:
L04AA18 Everolimus
Status:
active
Notice of Compliance (yyyy/mm/dd):
2009/12/14
Date Marketed in Canada (yyyy/mm/dd):
2010/02/12
Presentation:
Tablets: 5 mg; DIN: 02339501
Tablets: 10 mg; DIN: 02339528
Comments:
For treatment of metastatic renal cell carcinoma of clear cell morphology, after failure of initial treatment with either sunitnib or sorafenib.
| Posted | Updated |
|---|---|
| 2010-02-12 12:07 | 2010-02-12 12:09 |
Back to:
Drug Product Listings 
